Zacks Investment Research Upgrades Omega Healthcare Investors (NYSE:OHI) to Buy

Zacks Investment Research upgraded shares of Omega Healthcare Investors (NYSE:OHI) from a hold rating to a buy rating in a research report sent to investors on Wednesday, reports. The brokerage currently has $43.00 target price on the real estate investment trust’s stock.

According to Zacks, “Omega Healthcare Investors, Inc. was incorporated in the State of Maryland. It is a self-administered real estate investment trust (REIT), investing in income producing healthcare facilities, principally long-term care facilities located in the United States (U.S.) and the United Kingdom (U.K.). The Company provide lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs), independent living facilities and rehabilitation and acute care facilities. It has historically financed investments through borrowings under its revolving credit facilities, private placements or public offerings of its debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods. “

Several other research analysts have also recently issued reports on OHI. Smith Barney Citigroup raised their target price on shares of Omega Healthcare Investors from $30.00 to $37.00 in a report on Tuesday, December 15th. Jefferies Financial Group upgraded Omega Healthcare Investors from a hold rating to a buy rating and lifted their price objective for the company from $35.00 to $40.00 in a research note on Wednesday, January 13th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upped their target price on Omega Healthcare Investors from $30.00 to $37.00 in a research note on Tuesday, December 15th. TheStreet raised Omega Healthcare Investors from a c+ rating to a b- rating in a report on Monday. Finally, Mizuho downgraded Omega Healthcare Investors from a buy rating to a neutral rating and set a $36.00 price target for the company. in a report on Wednesday, January 13th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $36.03.

Omega Healthcare Investors stock opened at $39.16 on Wednesday. The business’s 50-day simple moving average is $37.41 and its two-hundred day simple moving average is $35.12. The company has a debt-to-equity ratio of 1.31, a quick ratio of 3.40 and a current ratio of 3.40. The company has a market cap of $9.08 billion, a PE ratio of 56.75, a PEG ratio of 2.47 and a beta of 1.03. Omega Healthcare Investors has a fifty-two week low of $23.89 and a fifty-two week high of $39.19.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Thursday, February 4th. The real estate investment trust reported $0.27 EPS for the quarter, missing the Zacks’ consensus estimate of $0.79 by ($0.52). Omega Healthcare Investors had a return on equity of 3.78% and a net margin of 17.99%. As a group, analysts predict that Omega Healthcare Investors will post 3.15 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 16th. Investors of record on Monday, February 8th were paid a $0.67 dividend. The ex-dividend date was Friday, February 5th. This represents a $2.68 dividend on an annualized basis and a yield of 6.84%. Omega Healthcare Investors’s dividend payout ratio is currently 87.30%.

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 25,000 shares of the stock in a transaction on Tuesday, March 30th. The shares were sold at an average price of $37.11, for a total transaction of $927,750.00. Following the transaction, the chief operating officer now directly owns 147,530 shares of the company’s stock, valued at $5,474,838.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders have acquired 1,500 shares of company stock valued at $55,695 over the last 90 days. 1.16% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the business. Penbrook Management LLC acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter worth approximately $31,000. Perigon Wealth Management LLC acquired a new stake in Omega Healthcare Investors during the 4th quarter worth $31,000. Manchester Financial Inc. purchased a new stake in shares of Omega Healthcare Investors during the fourth quarter worth $33,000. Curi Capital acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at about $36,000. Finally, Fieldpoint Private Securities LLC acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at about $46,000. 69.46% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: Most Active Stocks

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with's FREE daily email newsletter.